Schroder Investment Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-71,140
| Closed | -$10.8M | – | 1353 |
|
|
2022
Q3 | $10.8M | Buy |
71,140
+2,330
| +3% | +$352K | 0.02% | 595 |
|
|
2022
Q2 | $10M | Buy |
68,810
+1,486
| +2% | +$217K | 0.02% | 651 |
|
|
2022
Q1 | $7.95M | Buy |
67,324
+22,339
| +50% | +$2.64M | 0.01% | 726 |
|
|
2021
Q4 | $6.2M | Sell |
44,985
-19,856
| -31% | -$2.74M | 0.01% | 705 |
|
|
2021
Q3 | $9.01M | Sell |
64,841
-9,374
| -13% | -$1.3M | 0.01% | 653 |
|
|
2021
Q2 | $7.21M | Buy |
74,215
+20,287
| +38% | +$1.97M | 0.01% | 752 |
|
|
2021
Q1 | $3.69M | Buy |
53,928
+9,297
| +21% | +$635K | ﹤0.01% | 887 |
|
|
2020
Q4 | $3.83M | Sell |
44,631
-6,982
| -14% | -$598K | 0.01% | 861 |
|
|
2020
Q3 | $3.36M | Buy |
51,613
+4,355
| +9% | +$283K | 0.01% | 798 |
|
|
2020
Q2 | $3.46M | Buy |
47,258
+23,248
| +97% | +$1.7M | 0.01% | 728 |
|
|
2020
Q1 | $770K | Sell |
24,010
-6,426
| -21% | -$206K | ﹤0.01% | 940 |
|
|
2019
Q4 | $1.66M | Buy |
+30,436
| New | +$1.66M | ﹤0.01% | 906 |
|